Public Health Options

The following pages provide an overview and important links for each of the Meaningful Use public health options: Syndromic Surveillance, Immunization Information Systems, Electronic Laboratory Reporting, and Cancer Registry.

Population-based cancer surveillance is critical in North America for cancer control activities aimed at reducing the morbidity and mortality of cancer, the second leading cause of death in the United States…

Electronic Laboratory Reporting (ELR) is the electronic transmission from laboratories to public health of laboratory reports which identify reportable conditions…

As a part of the American Recovery and Reinvestment Act (ARRA), the meaningful use initiative requires participating healthcare providers to meet established public health criteria to receive EHR-MU incentives…

Public health syndromic surveillance using inpatient and ambulatory clinical care electronic health record (EHR) data is a relatively new practice…

The PHIN Messaging Guide for Syndromic Surveillance: Emergency Department, Urgent Care, Inpatient and Ambulatory Care Settings, Release 2.0 (April, 2015) is now available on the National Syndromic Surveillance Program (NSSP) Website (https://www.cdc.gov/nssp/news.html).

Reporting to registries is an integral part of improving population and public health…

For 2018, NHSN Antimicrobial Use (AU) and Antimicrobial Resistance (AR) (AUR) reporting have been identified as a new option for public health registry reporting under Meaningful Use Stage 3 (MU3)…

The Center for Disease Control and Prevention  (CDC), National Center for Health Statistics is currently accepting National Health Care Survey data from Eligible Professionals (EP), Eligible Hospitals (EH) and critical Access Hospitals (CAH) to fulfill the Meaningful Use EHR Incentive Programs Public Health Objective, Measure 3, submission of data for specialized registry reporting…

Page last reviewed: October 9, 2019